• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Occlusion (1984)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the resolute integrity rx coronary drug-eluting stent.Survey results from an interventional cardiologist in practice 12 years.In the past 12 months, the physician has used the resolute integrity stent 35 times.5 of the smallest (2.25 x 8 mm), 25 intermediate (2.25 x 12 mm to 4.00 x 34 mm) and 5 of the largest (4.00 x 38 mm) sizes of these stents were used.The following complications adverse events/effects were encountered in the using the resolute integrity product over the last 12 months: 3 coronary artery spasm events which were directly related to the device itself.It was stated that the coronary artery spasm events were associated specifically with the use of the device due to the coronary vessel diameter being overestimated.One of the 3 coronary artery spasm events required medical or surgical intervention.2 coronary artery dissection events which were directly related to the device itself.It was stated that the coronary artery dissection events were associated specifically with the use of the device due to the presence of massive calcification within the coronary artery.Both coronary artery dissection events required medical or surgical intervention.It was noted that none of the events above that were directly related to the device itself had previously been reported to medtronic.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
IE 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
IE  
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
IE  
091708734
MDR Report Key10250034
MDR Text Key198096197
Report Number9612164-2020-02502
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/22/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-